Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
A paedophile hoarding thousands of child sex abuse images has been jailed for three years after leaving his camera's memory card on a bus.
Seventy pupils at the Grange School in Runcorn were held in isolation for refusing to remove Marie Curie daffodils from their blazers.
A windy weekend. Rain clearing to sunshine & showers during Saturday. Cooler on Sunday with further showers following morning rain.